PLF Pharma are pleased to partner with Kings College London and the Medical Research Council. PLF Pharma will supply GMP pharmaceutical grade formulations along with placebos to facilitate the trials.
With medical cannabis still in its infancy in the UK, trials such as this are vital in providing both patient and prescriber confidence and perhaps more importantly, help further the understanding of the various active compounds and their effects when administered in different ratios or profiles.
Partnerships such as this underpins the company’s focus on being at the forefront of clinical research and supporting UK Universities
